The Paige digital pathology solution is designed to be compatible with existing laboratory technology, including most scanners, monitors, and laboratory information systems. The FDA-cleared and CE-marked Paige Platform features FullFocus™, an intuitive and responsive viewer for digital pathology slides, and a Data Management solution to store digital pathology slides. The integrated solution will allow for more streamlined logistics, faster turnaround times for pathology results, and more efficient support of internal and external laboratory service models. FullFocus™ will integrate into the Inform Diagnostics subspecialty anatomic pathology workflows and laboratory information system (LIS). Inform Diagnostics plans to immediately begin the implementation of the FullFocus™ digital pathology viewer.
#Inform diagnostics software
anatomic pathology provider, and Paige, a global leader in AI-based cancer diagnostic software for digital pathology, today announced an agreement to accelerate the use and optimization of digital pathology workflows at Inform Diagnostics. The United States press release concerning the settlement can be read here.Irving, TX and New York, NY /PRNewswire/ - Inform Diagnostics, a leading U.S. The settlement agreement in this case can be found here.
Wallace for shedding light on Inform's reflexive testing practices," stated fellow Morgan Verkamp partner Chandra Napora. "When laboratories conduct medically unnecessary testing, they put profit over the fiscal soundness of our healthcare system. Their dedication to take that risk in the interest of protecting taxpayers and the public fisc is inspiring," said Sonya Rao, a partner at Morgan Verkamp.
#Inform diagnostics professional
Wallace, take significant personal and professional risk to sound the alarm on fraud schemes. In the settlement, Inform admits that, from Januthrough January 31, 2018, Inform routinely and automatically conducted certain up-front stains on gastrointestinal and dermatological biopsy specimens without a pathologist's review of the routine stain and without an individual determination of whether the additional stain was medically necessary. Wallace.Īs part of the settlement, Inform has agreed to pay the United States $16 million. That investigation resulted in a settlement of False Claims Act allegations raised by Dr. The United States Attorney's Office for the District of Massachusetts led the investigation into Dr. Rather than perform only the laboratory tests ordered by physicians, Inform automatically and systematically ran additional tests, including special stains, without the treating physician's knowledge, consent, or order and without a pathologist's determination of medical necessity.
The complaint alleged that Inform submitted false claims to federal healthcare programs, like Medicare, for medically unnecessary laboratory testing. The matter was filed in the United States District Court for the District of Massachusetts. Inform Diagnostics, Inc., and the case number is 19-cv-10091. Wallace, a former pathologist at Inform, filed suit against the laboratory in January 2019, alleging violations of the False Claims Act, a law that allows whistleblowers to bring a case on behalf of the United States that alleges fraud on the government. Inform is a clinical laboratory, headquartered in Irving, Texas, that provides clinical pathology laboratory services to physicians and medical practices nationwide.ĭr. Christopher Wallace, the law firm of Morgan Verkamp, LLC (with attorneys in Cincinnati, Ohio, Boston, Massachusetts, and Tampa, Florida) is pleased to announce that the United States has resolved allegations of medically unnecessary pathology testing with Inform Diagnostics, Inc., formerly known as Miraca Life Sciences, Inc. BOSTON and CINCINNATI, J/PRNewswire/ - On behalf of its client, Dr.
0 kommentar(er)
